Sunday, April 13 | 10:30–11:30 a.m.
Ravindra Kolhe, M.D., Ph.D., Medical College of Georgia
This presentation explores our journey in Optical Genome Mapping (OGM) and its impact on diagnosing hematological malignancies. We will highlight how OGM enhances structural variant detection, improves risk stratification, and advances precision oncology. Join us as we discuss key challenges, successes, and the future of OGM in clinical practice.
After attending this presentation, participants should be able to:
• Analyze the role of Optical Genome Mapping (OGM) in detecting structural variations in hematological malignancies and compare it with conventional cytogenetic methods.
• Apply OGM data interpretation techniques to enhance diagnostic accuracy and risk stratification in hematological malignancies.
• Evaluate the impact of OGM on clinical decision-making and its integration into standard-of-care workflows for hematologic malignancies.
The program includes sessions, networking opportunities, industry spotlights and more.
View program
